Fox Chase Cancer Center

Articles

Shaping the Future of Care for Neuroendocrine Tumors

November 19th 2025

Fox Chase Cancer Center’s Namrata ‘Neena’ Vijayvergia, MD, an expert in gastrointestinal cancers and rare NETs, was recently recognized by two NET advocacy groups for her contributions to the field.

Researchers Develop New AI Tool That Makes Detection of Skin Cancer More Accurate

November 14th 2025

A new method enhances the ability of artificial intelligence models to detect and diagnose skin cancer in individuals with darker skin.

Fox Chase Cancer Center Breast Program Receives Accreditation for Sixth Consecutive Time

September 11th 2025

The NAPBC has renewed Fox Chase Cancer Center’s accreditation, making it the sixth consecutive time Fox Chase has been honored with this distinction.

Fox Chase Cancer Center Researchers Discover ‘Cell-in-Cell’ Mechanism That Blood Cancer Uses to Evade Treatment

August 19th 2025

Fox Chase Cancer Center revealed for the first time that cancer cells can evade anti-cancer drugs by entering and surviving within bone marrow fibroblasts.

Fox Chase Cancer Center and Temple Researchers Highlight Need For Molecular Testing in Diagnosing Two Types of Kidney Cancer

August 13th 2025

Genetic testing could help determine differences between rare forms of kidney cancer.

Novel Fox Chase Cancer Center Study Uses New Methods to Show How Fast Breast Cancers Grow and How Surgery Delays Affect Cancer Staging

August 8th 2025

Richard Bleicher, MD, FACS, discusses using a novel method to analyze tumor growth rates.

Fox Chase Cancer Center Researcher Helps Finds Key Resistance Mechanism in Breast Cancer That Could Lead to More Effective Treatment

July 10th 2025

New research from Fox Chase Cancer Center uncovers mechanisms of breast cancer resistance to CDK4/6 inhibitors and offers innovative treatment strategies.

Fox Chase Cancer Center Earns Renewal of Prestigious Core Grant from the National Cancer Institute

May 26th 2025

In a study recently published by researchers at Fox Chase Cancer Center, patients being treated for retroperitoneal sarcoma at multiple facilities experienced longer delays between diagnosis and treatment.

Fragmented Care Does Not Affect Survival Outcomes for Retroperitoneal Sarcoma, Fox Chase Cancer Center Study Finds

May 21st 2025

In a study recently published by researchers at Fox Chase Cancer Center, patients being treated for retroperitoneal sarcoma at multiple facilities experienced longer delays between diagnosis and treatment.

Fox Chase Cancer Center Researcher Secures Funding to Investigate Toxicity Reduction in Bladder Cancer Treatment

May 13th 2025

Fox Chase Cancer Center Researcher secures funding to investigate toxicity reduction in bladder cancer treatment.

Fox Chase Cancer Center Researcher Adria Hasan Honored With Scholar-in-Training Award From American Association for Cancer Research

May 2nd 2025

Fox Chase Cancer Center researcher Adria Hasan honored with scholar-in-training award from American Association for Cancer Research.

Fox Chase Cancer Center’s Dr. Jonathan Chernoff Elected to Association of American Physicians

April 30th 2025

Jonathan Chernoff, MD, PhD, Cancer Center Director of Fox Chase Cancer Center, was recently elected to the Association of American Physicians (AAP).

Fox Chase Cancer Center Physicians Open New Trial For Patients With Colorectal Cancer That Has Spread to the Liver

April 22nd 2025

Physicians at Fox Chase Cancer Center have begun accepting patients for a new clinical trial looking at the effectiveness of a HAI pump along with standard chemotherapy.

Fox Chase Cancer Center Study Shows That Examining More Lymph Nodes Was Associated With Improved Outcomes for Patients With Colon Cancer

April 4th 2025

Removing and testing more lymph nodes during surgery was associated with more accurate staging and better survival rates for patients with colon cancer.

Local Excision Possible for More Rectal Cancer Patients, Fox Chase Cancer Center Study Finds

April 1st 2025

Results from a study presented by Fox Chase Cancer Center suggest that chemotherapy followed by local excision is a promising treatment option for patients with node-negative low rectal cancer.

Fox Chase Cancer Center’s Jaye Gardiner Receives Research Grant From Uplifting Athletes

March 26th 2025

Jaye Gardiner, PhD, postdoctoral fellow at Fox Chase Cancer Center to receive a grant from the nonprofit Uplifting Athletes during its Young Investigators Draft.

Fox Chase Cancer Center’s Biosample Repository Receives Reaccreditation From College of American Pathologists

March 12th 2025

Fox Chase Cancer Center’s Biosample Repository Facility was recently awarded reaccreditation by the College of American Pathologists based on the results of an on-site inspection.

Fox Chase Cancer Center Researchers Review Role of AKT Pathway in Tumors and the Potential to Block it to Fight Cancer

March 7th 2025

Researchers at Fox Chase Cancer Center published 2 reviews on the role of AKT, also known as protein kinase B, in the development and treatment of cancer.

Fox Chase Cancer Center, Temple Health Study Reveals Timely Treatment Is Critical for Rectal Cancer Survival

February 28th 2025

Starting treatment within 60 days of initial evaluation significantly improves survival rates for patients with rectal cancer.

Some Patients With Kidney Cancer Can Stop Combination Treatment After Two Years, Fox Chase Cancer Center Study Finds

February 18th 2025

Some patients with metastatic kidney cancer achieving a good response to a combination therapy can safely stop or pause treatment after 2 years.

NEXT PAGE
PREVIOUS PAGE